CIK 0000109657
- Non-accelerated filer
- Smaller reporting company
GT Biopharma, Inc.
Sign in to watch- Ticker
- GTBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 941620407
- Phone
- +1 800-304-9888
- Business address
- 505 MONTGOMERY STREET, 10TH FLOOR, SAN FRANCISCO, CA, 94111
- Former names
- GT Biopharma, Inc., OXIS INTERNATIONAL INC
- 4 Open-market sale Former Officer and Director sold 396,300 shares at an average $0.29 ($113,427)
- 4 Open-market sale CEO sold 4,234,320 shares at $0.00 ($4,234)
- 4 Open-market sale CFO sold 2,269,708 shares at $0.00 ($2,270)
- 4 Grant or award CEO acquired 7,000,000 shares (grant or award)
- 4 Grant or award CFO acquired 4,500,000 shares (grant or award)
- 4 Open-market sale CEO sold 176,980 shares at $0.00 ($177)
- 4 Open-market sale Director sold 800,000 shares at $0.00 ($800)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Executive Chairman acquired 5,129,660 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CFO acquired 2,566,835 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 675,000 shares at $303,750.00 ($205,031,250,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 8 · 160 filings